President And Founder Of Seabreeze Capital Partners LP Dougie Kass Posts On X "We have moved to super size $MSOS and individual cannabis stocks in the belief that a favorable rescheduling announcement will come shortly."

IGC Pharma Receives Canadian Patent for Alzheimer's Agitation Drug Candidate IGC-AD1

IGC Pharma, Inc. announced that the Canadian Intellectual Property Office has granted a patent for its investigational oral therapy, IGC-AD1, which is currently in Phase 2 clinical trials for treating agitation in Alzheimer's dementia.

Aurora Cannabis Reports Fiscal Q2 2027 Financial Results

Aurora Cannabis Inc. announced its financial results for the second quarter of fiscal 2027, reporting C$86.0 million in net revenue and C$14.0 million in adjusted EBITDA.

8-K filing — Canopy Growth Corp (CGC)

Filed: 2026-11-06 AccNo: 0001193125-26-450716 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Aurora Cannabis Q2 EPS $(0.32) Misses $(0.09) Estimate, Sales $86.021M Beat $72.167M Estimate

Aurora Cannabis Reports Q2 Revenue of CA$86.0 Million

Aurora Cannabis announced its second-quarter financial results, reporting revenue of CA$86.0 million, which exceeded analyst expectations.

Cronos Group Reports 2026 Third Quarter Financial Results

Cronos Group Inc. announced its 2026 third quarter business results, reporting record net revenue, gross profit, and Adjusted EBITDA for the second consecutive quarter.